Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun;33(6):578-588.
doi: 10.1177/0269216319826007. Epub 2019 Feb 12.

Palliative care specialists in hospice and hospital/community teams predominantly use low doses of sedative medication at the end of life for patient comfort rather than sedation: Findings from focus groups and patient records for I-CAN-CARE

Bella Vivat  1 , Lucy Bemand-Qureshi  1 , Jane Harrington  1 , Sarah Davis  1 , Patrick Stone  1
Affiliations

Palliative care specialists in hospice and hospital/community teams predominantly use low doses of sedative medication at the end of life for patient comfort rather than sedation: Findings from focus groups and patient records for I-CAN-CARE

Bella Vivat et al. Palliat Med. 2019 Jun.

Abstract

Background: Little research has explored the detail of practice when using sedative medications at the end of life. One work package of the I-CAN-CARE research programme investigates this in UK palliative care.

Aims: To investigate current practices when using sedative medication at the end of life in London, UK, by (1) qualitatively exploring the understandings of palliative care clinicians, (2) examining documented sedative use in patient records and (3) comparing findings from both investigations.

Design: We conducted focus groups with experienced palliative care physicians and nurses, and simultaneously reviewed deceased patient records.

Setting/participants: In total, 10 physicians and 17 senior nurses in London hospice or hospital/community palliative care took part in eight focus groups. Simultaneously, 50 patient records for people who received continuous sedation at end of life in the hospice and hospital were retrieved and reviewed.

Results: Focus group participants all said that they used sedative medication chiefly for managing agitation or distress; selecting drugs and dosages as appropriate for patients' individual needs; and aiming to use the lowest possible dosages for patients to be 'comfortable', 'calm' or 'relaxed'. None used structured observational tools to assess sedative effects, strongly preferring clinical observation and judgement. The patient records' review corroborated these qualitative findings, with the median continuous dose of midazolam administered being 10 mg/24 h (range: 0.4-69.5 mg/24 h).

Conclusion: Clinical practice in these London settings broadly aligns with the European Association for Palliative Care framework for using sedation at the end of life, but lacks any objective monitoring of depth of sedation. Our follow-on study explores the utility and feasibility of objectively monitoring sedation in practice.

Keywords: Focus groups; hypnotics and sedatives; medical records; midazolam; nurses; palliative care; patient comfort; physicians.

PubMed Disclaimer

Conflict of interest statement

Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.

Figures

Figure 1.
Figure 1.
CSCI, PRN, and total midazolam for all 50 ‘CSCI patients’ in the last 24 h of life.
See this image and copyright information in PMC

References

    1. UK Parliamentary and Health Service Ombudsman. Dying without dignity, https://www.ombudsman.org.uk/publications/dying-without-dignity-0 (2015, accessed 21 August 2018).
    1. Palliative and end of life care priority setting partnership: putting patients, carers and clinicians at the heart of palliative and end of life care research, https://palliativecarepsp.files.wordpress.com/2015/01/peolcpsp_final_rep... (2015, accessed 21 August 2018).
    1. Stone P, Phillips C, Khullar M. Sedation in catastrophic incidents. Palliat Med 1997; 11: 253–254. - PubMed
    1. Caraceni A, Hanks G, Kaasa S, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 2012; 13: e58–e68. - PubMed
    1. Morita T, Tsuneto S, Shima Y. Definition of sedation for symptom relief: a systematic literature review and a proposal of operational criteria. J Pain Symptom Manage 2002; 24: 447–453. - PubMed

Publication types